Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 28, 2015; 21(44): 12558-12575
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12558
Published online Nov 28, 2015. doi: 10.3748/wjg.v21.i44.12558
Table 1 A list of hepatitis B virus vaccines in development
| Treatment | Undetectable HBV DNA inHBeAg positive patients | Anti-HBeAg serconversion in HBeAg positive patients | HBV DNA < 300/400 copies/mL in HBeAg negative patients |
| Pegylated interferon | 25 | 30 | 63 |
| Lamivudine | 39 | 22 | 72 |
| Adefovir | 21 | 12 | 51 |
| Entecavir | 67 | 22 | 90 |
| Telbivudine | 60 | 26 | 88 |
| Tenofovir disoproxil fumarate | 74 | 21 | 91 |
- Citation: Manzoor S, Saalim M, Imran M, Resham S, Ashraf J. Hepatitis B virus therapy: What’s the future holding for us? World J Gastroenterol 2015; 21(44): 12558-12575
- URL: https://www.wjgnet.com/1007-9327/full/v21/i44/12558.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i44.12558